Herbas VPB

Print
EN | LT
LT - Imuniteto moduliavimas ir solidinių navikų gydymas antikūnais, kurie specifiškai suriša CD38
EN - IMMUNE MODULATION AND TREATMENT OF SOLID TUMORS WITH ANTIBODIES THAT SPECIFICALLY BIND CD38

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/28 (2006.01)
A61K 39/39 (2006.01)
A61K 39/395 (2006.01)
C07K 16/30 (2006.01)
A61P 37/04 (2006.01)
A61P 35/00 (2006.01)
European patent
(11) Number of the document 3313441
(13) Kind of document T
(96) European patent application number 16815351.8
Date of filing the European patent application 2016-06-24
(97) Date of publication of the European application 2018-05-02
(45) Date of publication and mention of the grant of the patent 2024-02-21
(46) Date of publication of the claims translation 2024-05-27
PCT application
(86) Number PCT/US2016/039165
Date 2016-06-24
PCT application publication
(87) Number WO 2016/210223
Date 2016-12-29
Priority applications
(30) Number Date Country code
201562184018 P 2015-06-24 US
201562249546 P 2015-11-02 US
201562250566 P 2015-11-04 US
201562263307 P 2015-12-04 US
201662331489 P 2016-05-04 US
Inventors
(72)
AHMADI, Tahamtan , US
CASNEUF, Tineke , NL
LOKHORST, Henk M. , NL
MUTIS, Tuna , NL
SASSER, Amy , US
Grantee
(73) Janssen Biotech, Inc. , 800/850 Ridgeview Drive, Horsham, PA 19044, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Imuniteto moduliavimas ir solidinių navikų gydymas antikūnais, kurie specifiškai suriša CD38
  IMMUNE MODULATION AND TREATMENT OF SOLID TUMORS WITH ANTIBODIES THAT SPECIFICALLY BIND CD38
Last renewal fee
Payment date Validity (years) Amount
2025-05-19 10 231.00 EUR
Next renewal fee
2026-06-24